154 related articles for article (PubMed ID: 36313434)
21. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
[TBL] [Abstract][Full Text] [Related]
22. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
23. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
Jiang W; Guo Q; Wang C; Zhu Y
Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
Zhang H; Liu Y; Wang B; Wang C
BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
[TBL] [Abstract][Full Text] [Related]
25. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
26. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.
Zhang L; Su Z; Hong F; Wang L
Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925
[TBL] [Abstract][Full Text] [Related]
27. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
28.
Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
[TBL] [Abstract][Full Text] [Related]
29. Identification of SOX6 and SOX12 as Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma: A Retrospective Study Based on TCGA Database.
Lyu X; Zhang X; Sun LB; Cao XM; Zhang XH
Dis Markers; 2021; 2021():7190301. PubMed ID: 34868396
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analysis of m
Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
[TBL] [Abstract][Full Text] [Related]
31. Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma.
Li CS; Lu ZZ; Fang DL; Zhou WJ; Wei J
Transl Androl Urol; 2021 Jun; 10(6):2478-2492. PubMed ID: 34295734
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ
Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma.
Jiang Y; Gou X; Wei Z; Tan J; Yu H; Zhou X; Li X
Cancer Cell Int; 2020; 20():166. PubMed ID: 32435157
[TBL] [Abstract][Full Text] [Related]
34. Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma.
Jiang Y; Han D; Zhao Y; Zhang C; Shi X; Gu W
Front Immunol; 2022; 13():872170. PubMed ID: 35558077
[TBL] [Abstract][Full Text] [Related]
35. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
36. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma.
Ma T; Wang X; Wang J; Liu X; Lai S; Zhang W; Meng L; Tian Z; Zhang Y
Front Genet; 2021; 12():726369. PubMed ID: 34721523
[TBL] [Abstract][Full Text] [Related]
37. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
[TBL] [Abstract][Full Text] [Related]
38. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
Ghatalia P; Gordetsky J; Kuo F; Dulaimi E; Cai KQ; Devarajan K; Bae S; Naik G; Chan TA; Uzzo R; Hakimi AA; Sonpavde G; Plimack E
J Immunother Cancer; 2019 May; 7(1):139. PubMed ID: 31138299
[TBL] [Abstract][Full Text] [Related]
40. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
Xie W; Xi P; Liu Y; Zhang Z; Sun T
Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
